Literature DB >> 12941138

Interleukin-12 and interleukin-2-induced invariant natural killer T-cell cytokine secretion and perforin expression independent of T-cell receptor activation.

Runhua Hou1, Olga Goloubeva, Donna S Neuberg, Jack L Strominger, S Brian Wilson.   

Abstract

Human invariant natural killer (iNK) T cells expressing an invariant Valpha24-Jalpha15 T-cell receptor (TCR) are thought to be important regulators of autoimmunity and tumour surveillance. Two major subsets of iNK T cells, CD4+ or CD4- CD8- are known to exist, but the in vivo importance of CD4 expression is unclear. Since interleukin-12 (IL-12) is a key iNK T-cell-activating cytokine, the effect of IL-12 plus or minus the T-cell growth factor IL-2 on a large panel of CD4+ versus CD4- CD8- iNK T-cell clones was examined. Strikingly, IL-12 and IL-2 significantly activated iNK T cells to secrete IL-4, interferon-gamma and granulocyte-macrophage colony-stimulating factor, and up-regulated perforin expression in the absence of TCR stimulation. Furthermore, IL-2 and IL-12 treatment resulted in a preferential increase in apoptosis of CD4- CD8- clones. Thus, independent of TCR activation, IL-2 and IL-12 can directly activate iNK T cells and provide a selective advantage to the CD4+ iNK T-cell population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12941138      PMCID: PMC1783023          DOI: 10.1046/j.1365-2567.2003.01701.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  57 in total

1.  Effects of alpha-galactosylceramide (KRN7000), interleukin-12 and interleukin-7 on phenotype and cytokine profile of human Valpha24+ Vbeta11+ T cells.

Authors:  H J Van Der Vliet; N Nishi; Y Koezuka; M A Peyrat; B M Von Blomberg; A J Van Den Eertwegh; H M Pinedo; G Giaccone; R J Scheper
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

2.  IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells.

Authors:  D F DeBlaker-Hohe; A Yamauchi; C R Yu; J A Horvath-Arcidiacono; E T Bloom
Journal:  Cell Immunol       Date:  1995-10-01       Impact factor: 4.868

3.  High dose oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis.

Authors:  T Marth; W Strober; B L Kelsall
Journal:  J Immunol       Date:  1996-09-15       Impact factor: 5.422

4.  Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway.

Authors:  V Verhasselt; C Buelens; F Willems; D De Groote; N Haeffner-Cavaillon; M Goldman
Journal:  J Immunol       Date:  1997-03-15       Impact factor: 5.422

5.  Close phenotypic and functional similarities between human and murine alphabeta T cells expressing invariant TCR alpha-chains.

Authors:  F Davodeau; M A Peyrat; A Necker; R Dominici; F Blanchard; C Leget; J Gaschet; P Costa; Y Jacques; A Godard; H Vie; A Poggi; F Romagné; M Bonneville
Journal:  J Immunol       Date:  1997-06-15       Impact factor: 5.422

6.  Regulation of interleukin-12 receptor beta1 chain expression and interleukin-12 binding by human peripheral blood mononuclear cells.

Authors:  C Wu; R R Warrier; X Wang; D H Presky; M K Gately
Journal:  Eur J Immunol       Date:  1997-01       Impact factor: 5.532

7.  Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells.

Authors:  C Heufler; F Koch; U Stanzl; G Topar; M Wysocka; G Trinchieri; A Enk; R M Steinman; N Romani; G Schuler
Journal:  Eur J Immunol       Date:  1996-03       Impact factor: 5.532

8.  A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection.

Authors:  E Y Denkers; T Scharton-Kersten; S Barbieri; P Caspar; A Sher
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

9.  Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis.

Authors:  T Sumida; A Sakamoto; H Murata; Y Makino; H Takahashi; S Yoshida; K Nishioka; I Iwamoto; M Taniguchi
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

10.  T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons.

Authors:  J Estaquier; T Idziorek; W Zou; D Emilie; C M Farber; J M Bourez; J C Ameisen
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

View more
  7 in total

1.  Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR alpha-chain CDR3 loop.

Authors:  Mark A Exley; Runhua Hou; Angela Shaulov; Elena Tonti; Paolo Dellabona; Giulia Casorati; Omid Akbari; H Orhan Akman; Edward A Greenfield; Jenny E Gumperz; Jonathan E Boyson; Steven P Balk; S Brian Wilson
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 5.532

2.  Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11.

Authors:  Carlos J Montoya; David Pollard; Jeffrey Martinson; Kumud Kumari; Clive Wasserfall; Candice B Mulder; Maria T Rugeles; Mark A Atkinson; Alan L Landay; S Brian Wilson
Journal:  Immunology       Date:  2007-07-28       Impact factor: 7.397

3.  Lung cancer is associated with decreased expression of perforin, granzyme B and interferon (IFN)-γ by infiltrating lung tissue T cells, natural killer (NK) T-like and NK cells.

Authors:  G Hodge; J Barnawi; C Jurisevic; D Moffat; M Holmes; P N Reynolds; H Jersmann; S Hodge
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

4.  Natural killer T-cell autoreactivity leads to a specialized activation state.

Authors:  Xiaohua Wang; Xiuxu Chen; Lance Rodenkirch; William Simonson; Sarah Wernimont; Rachel M Ndonye; Natacha Veerapen; Darren Gibson; Amy R Howell; Gurdyal S Besra; Gavin F Painter; Anna Huttenlocher; Jenny E Gumperz
Journal:  Blood       Date:  2008-09-08       Impact factor: 22.113

5.  West Nile virus-infected human dendritic cells fail to fully activate invariant natural killer T cells.

Authors:  S Kovats; S Turner; A Simmons; T Powe; E Chakravarty; J Alberola-Ila
Journal:  Clin Exp Immunol       Date:  2016-09-22       Impact factor: 4.330

Review 6.  Insights Into Mucosal-Associated Invariant T Cell Biology From Studies of Invariant Natural Killer T Cells.

Authors:  Lucy C Garner; Paul Klenerman; Nicholas M Provine
Journal:  Front Immunol       Date:  2018-06-28       Impact factor: 7.561

7.  Peripheral immune tolerance by prolactin-induced protein originated from human invariant natural killer T cells.

Authors:  Hyeong-Woo Lee; Juhyun Shin; Brian S Wilson; Jae-Wook Oh
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.